Results 211 to 220 of about 273,408 (290)
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu +7 more
wiley +1 more source
The Feasibility of Developing a Universal SARS-CoV-2 Vaccine. [PDF]
Asaad M +8 more
europepmc +1 more source
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan +3 more
wiley +1 more source
The construction of recombinant DNA vaccine pVAX-ROP27-IL-2-IFN-γ and its immune enhancement effect against Eimeria tenella. [PDF]
Niu Z +9 more
europepmc +1 more source
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma [PDF]
Artyomov, Maxim N. +15 more
core +1 more source
ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han +5 more
wiley +1 more source
Bacteriophages as vaccine platforms: Opportunities and challenges in translation. [PDF]
Chen W, Peters DL, Lam S, Kettal M.
europepmc +1 more source
ABSTRACT For vaccination, the mechanisms of action of antigens and of immunostimulatory pathogen‐associated molecular pattern (PAMP) adjuvants are better understood than the roles of the depot, carrier, and other formulation‐related influences. Here, we carried out cytometric studies of vaccine formulations and the effect of adjuvant formulations on B ...
Egest J. Pone +3 more
wiley +1 more source
Silencing HPV: the rise of RNA therapeutics in cervical cancer. [PDF]
Khorramabadi SM +4 more
europepmc +1 more source

